Business
MMJ PhytoTech Ltd (MMJ.AX) New Cannabis Cultivation Site for Harvest One (TSXV:HVT)
Perth, Australia (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) ("MMJ") notes the attached ...
About this update from Delivra Health Brands Inc
[{"type":"text","content":"MMJ PhytoTech Ltd (MMJ.AX) New Cannabis Cultivation Site for Harvest One (TSXV:HVT)\nPerth, Australia (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) (\"MMJ\") notes the attached announcement (see link below) by Harvest One Cannabis Inc. (CVE:HVT) (\"Harvest One\") that its wholly owned subsidiary, United Greeneries, has entered into a five-year lease agreement, with three five year renewal options, for a mainland site (\"The Aldergrove Site\") that will meet all previous announced capacity targets. The Aldergrove Site will allow Harvest One to begin construction by the end of August 2018. The facility has a fully built 30,000 square foot building that will be used as the cultivation area and requires minimal renovations, which will allow for a rapid build out of the facility. The entire facility is comprised of over 59,000 square feet and will likely exceed the previously announced capacity target of 8,000kg of cannabis per annum. To view the announcement, please visit:http://abnnewswire.net/lnk/Q2M9G56Q \nAbout MMJ PhytoTech Ltd:In October 2017, MMJ PhytoTech Limited (ASX:MMJ) announced its strategy to become an incubator for strategic investments across regulated jurisdictions globally covering the entire cannabis value chain. Following the successful listing of United Greeneries Holdings Ltd (\"United Greeneries\") and Satipharm AG (\"Satipharm\") on the TSX-V through Harvest One Cannabis Inc. (CVE:HVT), MMJ has focused on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant value to the Company's shareholders. MMJ is actively pursuing early stage opportunities with the ability to deliver significant future revenue and the opportunity to provide dramatic global synergistic value as regulatory frameworks in key international markets continue to evolve. MMJ is targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D, hemp food products and retail. MMJ currently holds an equity stake of 53,333,333 shares in Harvest One, 100% ownership of Israeli-based R&D division PhytoTech Therapeutics Limited (\"PTL\") and strategic holdings in e-Sense Lab Limited (ASX:ESE) and private Canadian-based company WeedMe Inc. \nSource:MMJ PhytoTech Ltd\...